WASHINGTON, D.C. - A New Jersey federal judge erred in finding that two defendants infringed a patent for the reflux drug Prevacid but properly deemed the patent valid, the Federal Circuit U.S. Court of Appeals ruled Feb. 20 (Takeda Pharmaceutical Company Limited, et al. v. Zydus Pharmaceuticals USA Inc., No. 13-1406, Fed. Cir.).